IMC Chicago’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $207K | Buy |
38,400
+3,300
| +9% | +$19.7K | ﹤0.01% | 4978 |
|
|
2025
Q4 | $244K | Sell |
35,100
-37,900
| -52% | -$249K | ﹤0.01% | 3922 |
|
|
2025
Q3 | $471K | Buy |
73,000
+900
| +1% | +$6.15K | ﹤0.01% | 3206 |
|
|
2025
Q2 | $480K | Sell |
72,100
-8,100
| -10% | -$41.6K | ﹤0.01% | 2885 |
|
|
2025
Q1 | $519K | Sell |
80,200
-19,000
| -19% | -$137K | ﹤0.01% | 2627 |
|
|
2024
Q4 | $800K | Buy |
99,200
+9,900
| +11% | +$81.6K | ﹤0.01% | 2494 |
|
|
2024
Q3 | $729K | Sell |
89,300
-10,000
| -10% | -$65.9K | ﹤0.01% | 2215 |
|
|
2024
Q2 | $692K | Sell |
99,300
-68,800
| -41% | -$521K | ﹤0.01% | 2158 |
|
|
2024
Q1 | $1.78M | Sell |
168,100
-33,900
| -17% | -$296K | ﹤0.01% | 1434 |
|
|
2023
Q4 | $1.62M | Buy |
202,000
+24,800
| +14% | +$181K | ﹤0.01% | 1286 |
|
|
2023
Q3 | $1.46M | Buy |
177,200
+36,700
| +26% | +$316K | ﹤0.01% | 1091 |
|
|
2023
Q2 | $1.12M | Buy |
140,500
+17,600
| +14% | +$130K | ﹤0.01% | 1023 |
|
|
2023
Q1 | $995K | Sell |
122,900
-28,800
| -19% | -$231K | ﹤0.01% | 1036 |
|
|
2022
Q4 | $953K | Sell |
151,700
-49,900
| -25% | -$349K | ﹤0.01% | 1008 |
|
|
2022
Q3 | $1.39M | Buy |
201,600
+7,600
| +4% | +$52.8K | ﹤0.01% | 834 |
|
|
2022
Q2 | $1.62M | Buy |
194,000
+76,400
| +65% | +$1.07M | ﹤0.01% | 735 |
|
|
2022
Q1 | $2.69M | Buy |
117,600
+34,300
| +41% | +$838K | ﹤0.01% | 698 |
|
|
2021
Q4 | $2.3M | Sell |
83,300
-45,600
| -35% | -$1.22M | ﹤0.01% | 783 |
|
|
2021
Q3 | $3.59M | Buy |
128,900
+2,300
| +2% | +$65.2K | ﹤0.01% | 694 |
|
|
2021
Q2 | $3.71M | Sell |
126,600
-41,900
| -25% | -$1.27M | ﹤0.01% | 644 |
|
|
2021
Q1 | $5.35M | Buy |
168,500
+9,100
| +6% | +$267K | 0.01% | 553 |
|
|
2020
Q4 | $3.32M | Buy |
159,400
+25,200
| +19% | +$470K | ﹤0.01% | 630 |
|
|
2020
Q3 | $2.08M | Buy |
134,200
+24,500
| +22% | +$422K | ﹤0.01% | 576 |
|
|
2020
Q2 | $2.01M | Sell |
109,700
-89,700
| -45% | -$1.58M | ﹤0.01% | 559 |
|
|
2020
Q1 | $3.09M | Sell |
199,400
-95,300
| -32% | -$2.3M | 0.01% | 413 |
|
|
2019
Q4 | $8.82M | Buy |
294,700
+66,300
| +29% | +$1.72M | 0.02% | 237 |
|
|
2019
Q3 | $4.99M | Buy |
228,400
+57,500
| +34% | +$1.32M | 0.02% | 283 |
|
|
2019
Q2 | $4.31M | Buy |
170,900
+12,300
| +8% | +$292K | 0.01% | 304 |
|
|
2019
Q1 | $3.92M | Sell |
158,600
-17,900
| -10% | -$428K | 0.01% | 270 |
|
|
2018
Q4 | $3.26M | Buy |
+176,500
| New | +$4.2M | 0.01% | 267 |
|
Other funds holding BHC
PC
GAM
VCM
MP
KKRC
IMC Chicago's BHC Position: Q4 2024 in Review
IMC Chicago sold out of Bausch Health (BHC) in Q4 2024, closing a stake of 27,668 shares — an estimated $228K sold.
IMC Chicago first reported a position in BHC in Q4 2018 and held it in 12 quarters. The position peaked at $1.06M in Q1 2022. 225 funds tracked by Wall St. Rank hold BHC as of Q4 2024.
- IMC Chicago reported no remaining Bausch Health position as of Q4 2024 after selling out during the quarter.
- IMC Chicago sold 27,668 Bausch Health shares in Q4 2024, an estimated $228K.
- IMC Chicago first reported a position in Bausch Health in Q4 2018 and held it in 12 quarters.
- IMC Chicago's Bausch Health position peaked at $1.06M in Q1 2022.
- 225 funds tracked by Wall St. Rank held Bausch Health as of Q4 2024.
Based on IMC Chicago's 13F filing for Q4 2024, filed 27 Jan 2025.